A Single Center, Prospective, Randomized, Blinded Study to Evaluate the Efficacy and Safety of a Topical Tripeptide/Hexapeptide Anhydrous Gel When Used Pre- and Post- Hybrid Fractional Laser for the Treatment of Acne Scars

Mara Weinstein Velez1 Department of Dermatology, University of Rochester, Rochester, NY, USAView further author information

James Prezzano1 Department of Dermatology, University of Rochester, Rochester, NY, USA;2 Fayetteville Dermatology, Fayetteville, NY, USAView further author information

Michaela Bell3 Clinical Research Dept, Alastin Skincare, Inc. (A Galderma Company), Carlsbad, CA, USAView further author information

Alan Widgerow3 Clinical Research Dept, Alastin Skincare, Inc. (A Galderma Company), Carlsbad, CA, USA;4 Plastic Surgery Dept, Center for Tissue Engineering, University of California Irvine, Irvine, CA, USACorrespondence[email protected]

https://orcid.org/0000-0002-5705-8073 View further author information

A Single Center, Prospective, Randomized, Blinded Study to Evaluate the Efficacy and Safety of a Topical Tripeptide/Hexapeptide Anhydrous Gel When Used Pre- and Post- Hybrid Fractional Laser for the Treatment of Acne Scars

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A Single Center, Prospective, Randomized, Blinded Study to Evaluate the Efficacy and Safety of a Topical Tripeptide/Hexapeptide Anhydrous Gel When Used Pre- and Post- Hybrid Fractional Laser for the Treatment of Acne Scars

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date